Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > France

Please find below news from France as well as about organisations from this country.

Total search results: 1887 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Abivax S.A.. (3/14/19). "Press Release: Abivax 2018 Financial Results and Operations Update". Paris. 2019-03-14
Oxford BioMedica plc. (3/14/19). "Press Release: Oxford Biomedica plc Preliminary Results for the Year Ended 31 December 2018". Oxford. 2019-03-14
Abivax S.A.. (3/11/19). "Press Release: Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn’s and Colitis Organisation (ECCO)". Paris. 2019-03-11
Sartorius AG. (3/5/19). "Press Release: Sartorius Stedim Biotech and Novasep to Develop Novel Systems for Membrane Chromatography". Göttingen. 2019-03-05
Seventure Partners. (3/5/19). "Press Release: Health for Life Capital II, World Leading Microbiome-focused Fund Announces its First Close". Paris. 2019-03-05
Seventure Partners. (3/1/19). "Press Release: Seventure Partners Life Sciences Corporate Update September 2018 – February 2019". Paris. 2019-03-01
Genfit S.A.. (2/27/19). "Press Release: Genfit Files Registration Statement for Proposed Initial Public Offering in the United States". Lille & Cambridge, MA. 2019-02-27
Ynsect S.A.. (2/21/19). "Press Release: Ÿnsect Raises $125m to Become World Leader in Alternative Protein". Paris & London. 2019-02-21
PX’Therapeutics S.A.. (2/20/19). "Press Release: 2019 – PX’Therapeutics Develops Its Services Offer". 2019-02-20
Seventure Partners. (2/20/19). "Press Release: Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C". Paris. 2019-02-20
France Biotech. (2/19/19). "Press Release: France Biotech Announces Launch of HealthTech Investor Day in Paris on June 25th, 2019". Paris. 2019-02-19
Charles River Laboratories International, Inc.. (2/13/19). "Press Release: Charles River Laboratories Signs Binding Offer to Acquire CiToxLab". Wilmington, MA. 2019-02-13
Sanofi S.A.. (2/12/19). "Press Release: Sanofi Appoints Ameet Nathwani Chief Digital Officer". Paris. 2019-02-12
Grey Wolf Therapeutics Ltd.. (2/11/19). "Press Release: Grey Wolf Therapeutics Completes £10 Million ($14 Million) Series A Financing". Oxford. 2019-02-11
Symrise AG. (2/8/19). "Press Release: Symrise Successfully Completes Capital Increase. Strong Investor Demand – 5.614 Million New Shares Placed – Gross Proceeds amount of € 400 Million [Not for US, CA, AU or JP]". 2019-02-08
Oxford BioMedica plc. (2/7/19). "Press Release: Oxford Biomedica Provides Update on Programmes Outlicensed to Sanofi". Oxford. 2019-02-07
OSE Immunotherapeutics S.A.. (2/7/19). "Press Release: OSE Immunotherapeutics and Servier Announce First Option within Global License Agreement Exercised for further Clinical Development and Potential Commercialisation of OSE-127 in Autoimmune Diseases". 2019-02-07
Sanofi S.A.. (2/7/19). "Press Release: Sanofi Delivers 2018 Business EPS Growth of 5.1% at CER". Paris. 2019-02-07
bioMérieux S.A.. (2/7/19). "Press Release: bioMérieux Acquires Invisible Sentinel, a US-based Company Specialized in Food and Beverage Molecular Testing". Marcy l’Étoile. 2019-02-07
Sanofi S.A.. (2/6/19). "Press Release: FDA Approves Cablivi (caplacizumab-yhdp), the First Nanobody-based Medicine, for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. 2019-02-06
Sanofi S.A.. (2/6/19). "Press Release: Sanofi’s Board of Directors Notes the Resignation of Christian Mulliez and Co-opts Christophe Babule as Director". Paris. 2019-02-06
Sanofi S.A.. (2/5/19). "Press Release: Isatuximab Phase 3 Trial Meets Primary Endpoint of Prolonging Progression Free Survival in Patients with Relapsed/Refractory Multiple Myeloma". Paris. 2019-02-05
Sanofi S.A.. (2/4/19). "Press Release: CHMP Recommends Approval of Praluent (alirocumab) to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease". Paris & Tarrytown, NY. 2019-02-04
Sanofi S.A.. (1/30/19). "Press Release: Fexinidazole, the First All-oral Treatment for Sleeping Sickness, Approved in Democratic Republic of Congo". Paris & Geneva. 2019-01-30
Allogene Therapeutics, Inc.. (1/28/19). "Press Release: Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T™) Therapy". South San Francisco, CA & Paris. 2019-01-28
Sanofi S.A.. (1/17/19). "Press Release: FDA Advisory Committee Votes on Zynquista (sotagliflozin) as Treatment for Adults with Type 1 Diabetes". Paris & The Woodlands, TX. 2019-01-17
Carbios S.A.. (1/17/19). "Press Release: Carbios and TWB Receive €7.5 Million Funding to Accelerate the Industrialization of the Biorecycling of PET Plastics and Fibers". Clermont-Ferrand. 2019-01-17
ImaBiotech S.A.S.. (1/17/19). "Press Release: OCR and ImaBiotech Initiate a Strategic Partnership to Provide in situ Drug Efficacy and Target Exposure Services in Pets with Naturally Occuring Tumors". Lille. 2019-01-17
ImaBiotech S.A.S.. (1/17/19). "Press Release: Metabrain Research and ImaBiotech Initiate a Strategic Partnership to Offer Cuttingedge Preclinical Research Services in Metabolic Disorders". Lille. 2019-01-17
Nanobiotix S.A.. (1/16/19). "Press Release: Nanobiotix Plans to Conduct Registered Public Offering in the United States". Paris & Cambridge, MA. 2019-01-16
Biomunex Pharmaceuticals SASU. (1/15/19). "Press Release: Biomunex Pharmaceuticals Signs a Licensing Agreement with Sanofi for the Development of Bi- and Multi-specific Antibodies". Paris. 2019-01-15
Valneva S.E.. (1/7/19). "Press Release: Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate". Saint-Herblain. 2019-01-07
Valneva S.E.. (1/7/19). "Press Release: Valneva Announces Its Intention to Delist from the Vienna Stock Exchange. Trading Will Be Centralized on Euronext Paris". Saint-Herblain. 2019-01-07
Sanofi S.A.. (1/7/19). "Press Release: Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs". Paris & Tarrytown, NY. 2019-01-07
BioNTech AG. (1/4/19). "Press Release: Sanofi Invests EUR 80m (approx. USD 91.5m) in BioNTech as Partners Extend Collaboration and Advance mRNA-based Cancer Immunotherapy into Clinical Testing against Multiple Solid Tumors". Mainz. 2019-01-04
Valneva S.E.. (12/21/18). "Press Release: Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate". Saint-Herblain. 2018-12-21
Novartis AG. (12/20/18). "Press Release: Novartis Announces Offer to Acquire CellforCure to Expand Manufacturing Capacity for Innovative Cell and Gene Therapies". Basel. 2018-12-20
Novartis AG. (12/20/18). "Press Release: Novartis Announces New CEO of Oncology Business Unit". Basel. 2018-12-20
Protagen AG. (12/18/18). "Press Release: Protagen AG Appoints Immuno-Oncology Experts to Its Scientific Advisory Board". 2018-12-18
Sanofi S.A.. (12/18/18). "Press Release: Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq". Paris. 2018-12-18
Carmat S.A.. (12/17/18). "Press Release: The European Investment Bank Supports Carmat with €30 Million for the Marketing Process of Its Total Artificial Heart". Paris. 2018-12-17
Valneva S.E.. (12/17/18). "Press Release: Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate". Saint-Herblain. 2018-12-17
Kurma Partners. (12/14/18). "Press Release: Kurma Partners Announces the First Closing of Kurma Biofund III". Paris. 2018-12-14
Polyplus-transfection S.A.. (12/13/18). "Press Release: Polyplus-transfection further Expands Transfection Reagent Portfolio for Cell and Gene Therapy GMP production". Strasbourg. 2018-12-13
Minoryx Therapeutics S.L.. (12/13/18). "Press Release: Minoryx Therapeutics Announces Early Completion of Patient Randomization in the ADVANCE Trial – a Phase 2/3 Clinical Study of MIN-102 in X-ALD Patients". Mataró, Barcelona. 2018-12-13
Carmat S.A.. (12/12/18). "Press Release: Carmat Announces the Appointment of Pascale d’Arbonneau as Chief Financial Officer". Paris. 2018-12-12
Merck KGaA. (12/10/18). "Press Release: Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models". Darmstadt. 2018-12-10
Abivax S.A.. (12/6/18). "Press Release: Abivax Receives DSMB Recommendation to Continue Ongoing Extension Study of Its Completed Phase 2a Clinical Trial in Ulcerative Colitis patients". Paris. 2018-12-06
Valneva S.E.. (12/6/18). "Press Release: Valneva and Hookipa Sign a Collaboration and Manufacturing Agreement". Saint-Herblain & Vienna. 2018-12-06
L’Oréal S.A.. (12/5/18). "Press Release: L'Oréal Creates a Corporate Venture Capital Fund Dedicated to Accompanying Innovative Startups". Clichy. 2018-12-05
Domain Therapeutics S.A.. (12/4/18). "Press Release: Domain Therapeutics Signs a Multi-target Research Collaboration and License Agreement with Boehringer Ingelheim on G Protein-Coupled Receptors (GPCRs) for Central Nervous System Disorders". Strasbour 2018-12-04
Anagenesis Biotechnologies. (12/4/18). "Press Release: Anagenesis Biotechnologies Announces a €3 Million Investment by the Boehringer Ingelheim Venture Fund and Cap Innov’Est". Strasbourg. 2018-12-04
Allogene Therapeutics, Inc.. (12/3/18). "Press Release: Allogene Therapeutics Presents Data from Preclinical Study of ALLO-715 (anti-BCMA) Demonstrating Allogeneic CAR T Potential in Multiple Myeloma at the 2018 ASH Annual Meeting". South San Francisco, 2018-12-03
Allogene Therapeutics, Inc.. (12/3/18). "Press Release: Allogene Therapeutics and Servier Present Pooled Data from Phase 1 Trials of Allogeneic UCART19 in Relapsed/Refractory Acute Lymphoblastic Leukemia". South San Francisco, CA & Paris. 2018-12-03
Polyplus-transfection S.A.. (11/29/18). "Press Release: Polyplus-transfection Launches a Powerful Nanotechnology for DNA Transfection Composed of jetOptimus Reagent". 2018-11-29
Carbios S.A.. (11/28/18). "Press Release: Carbios and Kem One Sign a Letter of Intent to Implement a PET Biorecycling Demonstration Plant Operated by Carbios in the French Chemical Valley". Clermont-Ferrand. 2018-11-28
Novadiscovery. (11/22/18). "Press Release: Novadiscovery Welcomes Two New Members to Its Team to Strengthen Its Combined Expertise in Artificial Intelligence and Clinical Medicine". Lyon. 2018-11-22
Stilla Technologies S.A.S.. (11/20/18). "Press Release: Stilla Technologies Completes €16 Million ($18 Million) Series A". Paris. 2018-11-20
3B Pharmaceuticals GmbH. (11/20/18). "Press Release: Ipsen and 3BP Announce First Patient Dosed in Phase I/II Study for First-in-class Radionuclide (IPN01087)". Paris. 2018-11-20
Denali Therapeutics Inc.. (11/19/18). "Press Release: Denali Therapeutics Announces Positive Clinical Results with Its Lead RIPK1 Inhibitor Molecule and Intention to Initiate Patient Studies in Multiple Indications in Collaboration With Sanofi". South Sa 2018-11-19
Ipsen S.A.. (11/15/18). "Press Release: European Commission Approves Ipsen’s Cabometyx (cabozantinib) for the Treatment of Hepatocellular Carcinoma in Adults Previously Treated with Sorafenib". Paris. 2018-11-15
Lonza Group Ltd.. (11/15/18). "Press Release: Lonza and Sartorius Stedim Biotech Modify Relationship for Supply of Cell Culture Media". Basel & Aubagne. 2018-11-15
Quantum Genomics S.A.. (11/12/18). "Press Release: Quantum Genomics Announces Excellent Topline Results from Phase 2b NEW-HOPE Study Evaluating Firibastat for Arterial Hypertension". Paris & New York, NY. 2018-11-12
IntegraGen S.A.. (11/12/18). "Press Release: IntegraGen Announces Collaboration with Google Cloud to Offer Large Scale Genomic Analysis Tools for Clinicians and Medical Researchers". Paris. 2018-11-12
bioMérieux S.A.. (11/9/18). "Press Release: bioMérieux Acquires a Majority Stake in Hybiome and Strengthens Its Presence Both in China and in the Immunoassay Market". Marcy l’Étoile. 2018-11-09
Edinburgh Molecular Imaging Ltd.. (11/8/18). "Press Release: Edinburgh Molecular Imaging Appoints Bernhard Sixt as New Chief Executive Officer". Edinburgh. 2018-11-08
Bone Therapeutics S.A.. (11/7/18). "Press Release: Bone Therapeutics Business Update for Third Quarter 2018". Gosselies. 2018-11-07
Sanofi S.A.. (11/1/18). "Press Release: Sanofi and Denali Therapeutics to Develop Treatments for Neurological and Inflammatory Diseases". Paris. 2018-11-01
Denali Therapeutics Inc.. (11/1/18). "Press Release: Denali Therapeutics Announces Broad Collaboration with Sanofi to Develop RIPK1 Inhibitors for the Treatment of Neurological and Inflammatory Diseases". South San Francisco, CA. 2018-11-01
Allogene Therapeutics, Inc.. (11/1/18). "Press Release: Allogene Therapeutics Announces Data Presentations Supporting Its Allogeneic CAR T Pipeline Program at 60th American Society of Hematology (ASH) Annual Meeting". South San Francisco, CA. 2018-11-01
Sanofi S.A.. (10/31/18). "Press Release: Sanofi Q3 2018 Performance Confirms Return to Growth". Paris. 2018-10-31
PathoQuest S.A.S.. (10/31/18). "Press Release: PathoQuest Achieves Illumina Propel Certification". 2018-10-31
Magnisense SE. (10/24/18). "Press Release: Magnisense Successfully Raises € 5 Nillion to Boost the Commercial Development of Its MiAG Emergency Diagnostic Tests for Heart Diseases". Paris. 2018-10-24
Microbiotica Ltd.. (10/24/18). "Press Release: Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital Fund". Cambridge. 2018-10-24
Enterome S.A.. (10/23/18). "Press Release: Enterome Signs Global Licensing, Co-development and Co-Promotion Agreement with Takeda for the Treatment of Crohn’s Disease". Paris & Cambridge, MA. 2018-10-23
Innate Pharma S.A.. (10/23/18). "Press Release: Innate Pharma Strengthens and Expands Its Oncology Development Collaboration with AstraZeneca". Marseille. 2018-10-23
Hybrigenics S.A.. (10/23/18). "Press Release: Clinical Study of Inecalcitol in Acute Myeloid Leukemia Stopped for Futility. The Clinical Development of Inecalcitol Is Discontinued". Paris. 2018-10-23
Acticor Biotech. (10/17/18). "Press Release: Acticor Biotech Raises €15.3M in a Series B Financing". Paris. 2018-10-17
Sanofi S.A.. (10/16/18). "Press Release: Dupixent (dupilumab) Showed Positive Topline Results in Two Phase 3 trials of Patients with Chronic Rhinosinusitis with Nasal Polyps". Paris & Tarrytown, NY. 2018-10-16
Boehringer Ingelheim. (10/12/18). "Press Release: Boehringer Ingelheim Inaugurates Its New Global Centre for Veterinary Vaccine R&D in Lyon, France". Lyon. 2018-10-12
Adocia S.A.. (10/11/18). "Press Release: Adocia Informs about a Civil Action Filed by Eli Lilly". Lyon. 2018-10-11
Rgenix, Inc.. (10/9/18). "Press Release: Rgenix Raises $40M in Series C Funding To Support Clinical Stage Oncology Programs". New York, NY. 2018-10-09
Euronext N.V.. (10/8/18). "Press Release: Medincell Lists on Euronext Paris. €30 Million Raised, Market Capitalisation €144 Million". Paris. 2018-10-08
Evotec AG. (10/4/18). "Press Release: Evotec Signs Agreement with Sanofi to Advance Early Stage Academic Research into Novel Therapeutic Candidates". Hamburg. 2018-10-04
Novasep S.A.. (10/2/18). "Press Release: Novasep Opens €27m New Viral Vector Commercial Production Facility". Lyon. 2018-10-02
Sanofi S.A.. (10/1/18). "Press Release: Sanofi Completes Divestiture of Zentiva to Advent". Paris. 2018-10-01
Sanofi S.A.. (9/28/18). "Press Release: FDA Approves Libtayo (cemiplimab-rwlc) as First and Only Treatment for Advanced Cutaneous Squamous Cell Carcinoma". Paris & Tarrytown, NY. 2018-09-28
Valneva S.E.. (9/27/18). "Press Release: Valneva Raises €50 Million in Oversubscribed Placement Led by US Healthcare Investors [Not for Distribution in the United States, Canada, Australia or Japan]". Saint-Herblain. 2018-09-27
Valneva S.E.. (9/26/18). "Press Release: Valneva Launches a Capital Increase of Approximately €40 Million [Not for Distribution in the United States, Canada, Australia or Japan]". Saint-Herblain. 2018-09-26
Novacyt S.A.. (9/26/18). "Press Release: Novacyt Half Year 2018 Results. Molecular Product Revenues up 18% to €3m – Gross Margin Increases to 64%". Paris & Camberley. 2018-09-26
genOway S.A.. (9/25/18). "Press Release: genOway Announces the Acquisition of Axenis to Create the Largest Offer of Preclinical Models in the Immuno-oncology and Immuno-inflammation Space". Lyon. 2018-09-25
PathoQuest S.A.S.. (9/25/18). "Press Release: PathoQuest Names Dr. Christiane Honisch to Board of Directors". Paris. 2018-09-25
Thermo Fisher Scientific Inc.. (9/24/18). "Press Release: New Single Quadrupole Mass Spectrometry Technology Designed for Chromatographers Performing LC-MS Routine Analysis". Cannes-Mandelieu. 2018-09-24
Erytech Pharma. (9/20/18). "Press Release: Erytech Announces Enrollment of First Patients in Phase 3 Clinical Trial Evaluating Eryaspase for the Treatment of Second Line Pancreatic Cancer". Lyon & Cambridge, MA. 2018-09-20
Valneva S.E.. (9/20/18). "Press Release: Valneva Announces Extension of Drawdown Period for Its Existing European Investment Bank Loan". Saint-Herblain. 2018-09-20
Cellectis S.A.. (9/19/18). "Press Release: CAR-T Pioneer Dr. Stephan A. Grupp to Join Cellectis Clinical Advisory Board". New York, NY. 2018-09-19
GeNeuro S.A.. (9/18/18). "Press Release: GeNeuro Regains Worldwide Rights ex US and Japan to GNbAC1 in Multiple Sclerosis from Servier". Paris & Geneva. 2018-09-18
Horama S.A.. (9/18/18). "Press Release: Horama Completes Its 22.5 Million Euros Series B Financing Round". Paris. 2018-09-18
GamaMabs Pharma S.A.. (9/17/18). "Press Release: GamaMabs Pharma Starts a Phase 2 Study of Monoclonal Antibody GM102 in Patients with Advanced or Metastatic Colorectal Cancer". Paris & Toulouse. 2018-09-17
Sanofi S.A.. (9/15/18). "Press Release: Positive Phase 3 Results Presented for Dupixent (dupilumab) Show Significant Improvement on Multiple Measures of Disease Severity in Adolescents with Moderate-to-Severe Atopic Dermatitis". Paris & Tarrytown, NY. 2018-09-15
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top